<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In patients with sinoatrial nodal (SAN) dysfunction, atrial pauses lasting several seconds may follow rapid atrial pacing or <z:hpo ids='HP_0006688'>paroxysmal tachycardia</z:hpo> (tachy-brady <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical studies suggest that <z:chebi fb="3" ids="16335">adenosine</z:chebi> may play an important role in SAN dysfunction, but the mechanism remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To define the mechanism of SAN dysfunction induced by the combination of <z:chebi fb="3" ids="16335">adenosine</z:chebi> and <z:hpo ids='HP_0001649'>tachycardia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied the mechanism of SAN dysfunction produced by a combination of <z:chebi fb="3" ids="16335">adenosine</z:chebi> and rapid atrial pacing in isolated coronary-perfused canine atrial preparations by using high-resolution optical mapping (n = 9) </plain></SENT>
<SENT sid="4" pm="."><plain>Sinus cycle length and sinoatrial conduction time (SACT) were measured during <z:chebi fb="3" ids="16335">adenosine</z:chebi> (1-100 μM) and DPCPX (1 μM; A1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>; n = 7) perfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Sinoatrial node recovery time was measured after 1 minute of "slow" pacing (3.3 Hz) or tachypacing (7-9 Hz) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="3" ids="16335">Adenosine</z:chebi> significantly increased sinus cycle length (477 ± 62 ms vs 778 ± 114 ms; P&lt;.01) and SACT during sinus rhythm (41 ± 11 ms vs 86 ± 16 ms; P&lt;.01) in a dose-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> dramatically affected SACT of the first SAN beat after tachypacing (41 ± 5 ms vs 221 ± 98 ms; P&lt;.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, at high concentrations of <z:chebi fb="3" ids="16335">adenosine</z:chebi> (10-100 μM), termination of tachypacing or <z:hpo ids='HP_0004749'>atrial flutter</z:hpo>/<z:mp ids='MP_0006109'>fibrillation</z:mp> produced atrial pauses of 4.2 ± 3.4 seconds (n = 5) owing to conduction block between the SAN and the atria, despite a stable SAN intrinsic rate </plain></SENT>
<SENT sid="9" pm="."><plain>Conduction block was preferentially related to depressed excitability in SAN conduction pathways </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi>-induced changes were reversible on washout or DPCPX treatment </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These data directly demonstrate that <z:chebi fb="3" ids="16335">adenosine</z:chebi> contributes to post-<z:hpo ids='HP_0001649'>tachycardia</z:hpo> atrial pauses through SAN exit block rather than slowed pacemaker automaticity </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, these data suggest an important modulatory role of <z:chebi fb="3" ids="16335">adenosine</z:chebi> in <z:e sem="disease" ids="C0221047" disease_type="Disease or Syndrome" abbrv="">tachy-brady syndrome</z:e> </plain></SENT>
</text></document>